Trial Profile
Single-arm phase II trial of fruquintinib in patients with solid tumours
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Oct 2013
Price :
$35
*
At a glance
- Drugs Fruquintinib (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- Sponsors Hutchison MediPharma
- 15 Oct 2013 New trial record
- 09 Oct 2013 Results are expected in early 2014, according to a Hutchison MediPharma media release.